Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Version
05/28/2019
Revision date
2019-05-28
Product name
3% Sodium Chloride, USP Solution for Infusion
Product name
3% Sodium Chloride, USP Solution for Infusion
Identification on the label/Trade name
3% Sodium Chloride, USP Solution for Infusion | Manufacturer Fresenius Kabi USA LLC
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
WARNING
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
Signal word
WARNING. GHS Class Eye Irritation. Category 2.
Hazard statements
Causes serious eye irritation.
Precautionary statements
Wash hands thoroughly after handling. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye Contact with eyes may cause irritation. Skin May cause skin irritation. Inhalation May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms Adverse reactions from prescribed doses include: febrile response, local tenderness, abscess, tissue necrosis, infection at injection site, venous thrombosis, phlebitis extending from the site of injection, and extravasation. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with hypernatremia or fluid retention. Conditions
